Back to Agenda
SESSION 11; part 2: Status and Changes in Relation to Current Disclosure Requirements in EU and the USA
Speaker(s)
The Final Rule for FDAAA and ClinicalTrials.gov Requirements
Rebecca Williams, PharmD, MPH
Essex, Part of Emmes Group, United States
Senior Clinical Trials Subject Matter Expert
Have an account?